Results

1–7 of 7 results for CLS-TA

Post Hoc Analysis of Suprachoroidal CLS-TA Versus Real-World Rescue Therapies for Uveitic Macular Edema: Safety and Visual Function
Steven Yeh, MD
Annual Meeting Talks
2021
Results From the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post Hoc Analysis
Ashvini K. Reddy, MD
Annual Meeting Talks
2020
Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes: Results of the Phase 3 PEACHTREE Study
Christopher R Henry, MD
Updates from the Field
2019
Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks
Pauline T. Merrill, MD, FASRS
Annual Meeting Talks
2019
Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes
Christopher R Henry, MD
Annual Meeting Talks
2019
Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019
Suprachoroidally Injected CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveitis: Results of the Phase 3 PEACHTREE Study
Steven Yeh, MD
Annual Meeting Talks
2018